Skip to main content
Insights

Due diligence best practices

In this report, we've gathered eight best practices from top pharma companies that keep the process efficient and compliant.

Drive the right decisions forward

The goal is to carefully evaluate the opportunity, highlight important risks, refine the business case, validate its assumptions and consider the fit with the acquiring organization's strategy and vision.

Start with the showstoppers

“When we go to diligence and look at a Phase II or III asset, that can be 25-30 world class experts across the entire value chain. That's like between 300 to 500 years of drug discovery and development experience that you're deploying to review a data package.”

Kick off the due diligence together

Filter and prioritize information requests

Focus on security and compliance

Use appropriate tools

Create a structured evaluation process

Tell a story

Document the history of your diligence

“When we go to diligence and look at a Phase II or III asset, that can be 25-30 world class experts across the entire value chain. That's like between 300 to 500 years of drug discovery and development experience that you're deploying to review a data package.”

We help bring science to life.

Products
Connect
Deal
Event
Get started
Network
About
Global Challenges
Campaigns
Join the network
Platform
Holistic partnering
Connecting
Networking
Execution
Trust
Security & Compliance
Resources
Blog
Partnering insights
Product updates
Help center
Excellence calculator
Labiotech.eu
Company
About us
Contact us
© 2023 Inpart Privacy policy Terms of use